Project BioShield Legislation Would Provide Emergency Powers to FDA for Approval of Medical Countermeasures
On July 21, 2004, the President signed into law the "Project BioShield Act of 2004" (Pub. L. No. 108-276).
The Project BioShield Act addresses the lack of a commercial market for research, development, and deployment of medical countermeasures against biological, chemical, radiological, and nuclear wea